ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Waxman Subcommittee Hears Support For Cancer Act Renewal

March 7, 1980

Health Reform Plans Offer Difficult Choices For Patients, Researchers, Practitioners

February 25, 1994

FDA developing guidelines for oncology endpoints.

May 7, 2004

Louis Sullivan Blasts Tobacco, Sports Links

May 10, 1991

NIH News: PubMed Central Is Name Of New NIH PLAN For Electronic Publishing

September 10, 1999

Natcher Subcommittee Open Door To justification for Increasing Cancer Program 1982 Appropriation

April 3, 1981